Literature DB >> 22229577

The G-protein coupled receptor family: actors with many faces.

George Liapakis1, Liapakis George, Arnau Cordomí, Cordomi Arnau, Leonardo Pardo, Pardo Leonardo.   

Abstract

G-protein coupled receptors (GPCRs) comprise the largest family of proteins in our body, which have many important physiological functions and are implicated in the pathophysiology of many serious diseases. GPCRs therefore are significant targets in pharmaceutical research. GPCRs share the common architecture of seven plasma membrane-spanning segments connected to each other with three extracellular and three intracellular loops. In addition, GPCRs contain an extracellular N-terminal region and an intracellular C-terminal tail. GPCRs could stimulate different intracellular G-proteins (internal stimuli) and signaling pathways after their interaction with different ligands (external stimuli). The exceptional functional plasticity of GPCRs could be attributed to their inherent dynamic nature to adopt different active conformations, which are stabilized differentially by different stimuli as well as by several mutations. This review describes the structural changes of GPCRs associated with their activation. Understanding the dynamic nature of GPCRs could potentially contribute in the development of future structure-based approaches to design new receptor-specific, signaling-selective ligands, which will enrich the pharmaceutical armamentarium against various diseases.

Mesh:

Substances:

Year:  2012        PMID: 22229577     DOI: 10.2174/138161212799040529

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Investigation of the conformational dynamics of the apo A2A adenosine receptor.

Authors:  Alisha D Caliman; Sara E Swift; Yi Wang; Yinglong Miao; J Andrew McCammon
Journal:  Protein Sci       Date:  2015-04-10       Impact factor: 6.725

Review 2.  [Novel achievements in development and application of GPCR-peptides].

Authors:  A O Shpakov; K V Derkach
Journal:  Zh Evol Biokhim Fiziol       Date:  2015 Jan-Feb

Review 3.  Protein Design: From the Aspect of Water Solubility and Stability.

Authors:  Rui Qing; Shilei Hao; Eva Smorodina; David Jin; Arthur Zalevsky; Shuguang Zhang
Journal:  Chem Rev       Date:  2022-08-03       Impact factor: 72.087

Review 4.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

5.  Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonism.

Authors:  Katerina Spyridaki; Minos-Timotheos Matsoukas; Arnau Cordomi; Kostas Gkountelias; Maria Papadokostaki; Thomas Mavromoustakos; Diomedes E Logothetis; Andrew N Margioris; Leonardo Pardo; George Liapakis
Journal:  J Biol Chem       Date:  2014-05-16       Impact factor: 5.157

6.  GPCRtm: An amino acid substitution matrix for the transmembrane region of class A G Protein-Coupled Receptors.

Authors:  Santiago Rios; Marta F Fernandez; Gianluigi Caltabiano; Mercedes Campillo; Leonardo Pardo; Angel Gonzalez
Journal:  BMC Bioinformatics       Date:  2015-07-02       Impact factor: 3.169

7.  The role of Cysteine 6.47 in class A GPCRs.

Authors:  Mireia Olivella; Gianluigi Caltabiano; Arnau Cordomí
Journal:  BMC Struct Biol       Date:  2013-03-15

8.  Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management.

Authors:  Dinorah Leyva-Illades; Sharon Demorrow
Journal:  Cancer Manag Res       Date:  2013-07-01       Impact factor: 3.989

9.  GPCR-SAS: A web application for statistical analyses on G protein-coupled receptors sequences.

Authors:  José Carlos Gómez Tamayo; Mireia Olivella; Santiago Ríos; Marlous Hoogstraat; Angel Gonzalez; Eduardo Mayol; Xavier Deupi; Mercedes Campillo; Arnau Cordomí
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.